Seer to Participate in the TD Cowen 45th Annual Health Care Conference
Seer (Nasdaq: SEER), a pioneering life sciences company focused on proteomics platform commercialization, has announced its participation in the TD Cowen 45th Annual Healthcare Conference in Boston, MA.
The company's management team will engage in a fireside chat scheduled for Tuesday, March 4th at 11:50 a.m. Eastern Time (8:50 a.m. Pacific Time). Investors and interested parties can access a live webcast of the session through the Investor section of Seer's website at investor.seer.bio. An archived replay will be made available on the company's website after the conference concludes.
Seer (Nasdaq: SEER), una società pionieristica nel settore delle scienze della vita concentrata sulla commercializzazione della piattaforma proteomica, ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Salute TD Cowen a Boston, MA.
Il team di gestione dell'azienda parteciperà a un fireside chat programmato per martedì 4 marzo alle 11:50 ora orientale (8:50 ora del Pacifico). Gli investitori e le parti interessate possono accedere a un webcast dal vivo della sessione attraverso la sezione Investor del sito web di Seer all'indirizzo investor.seer.bio. Una registrazione archiviata sarà disponibile sul sito web dell'azienda dopo la conclusione della conferenza.
Seer (Nasdaq: SEER), una empresa pionera en ciencias de la vida centrada en la comercialización de plataformas de proteómica, ha anunciado su participación en la 45ª Conferencia Anual de Salud de TD Cowen en Boston, MA.
El equipo de gestión de la empresa participará en un fireside chat programado para el martes 4 de marzo a las 11:50 a.m. hora del Este (8:50 a.m. hora del Pacífico). Los inversores y partes interesadas pueden acceder a un webcast en vivo de la sesión a través de la sección de Inversores del sitio web de Seer en investor.seer.bio. Se pondrá a disposición una repetición archivada en el sitio web de la empresa después de que concluya la conferencia.
Seer (Nasdaq: SEER)는 단백질체 플랫폼 상용화에 중점을 둔 선도적인 생명과학 회사로, 매사추세츠주 보스턴에서 열리는 TD Cowen 제45회 연례 의료 회의에 참가한다고 발표했습니다.
회사의 경영진은 동부 표준시 기준으로 3월 4일 화요일 오전 11시 50분 (태평양 표준시 기준 오전 8시 50분)에 예정된 파이어사이드 채팅에 참여할 것입니다. 투자자 및 관심 있는 당사자는 Seer의 웹사이트 투자자 섹션을 통해 세션의 실시간 웹캐스트에 접근할 수 있습니다. 회의가 종료된 후 회사 웹사이트에서 기록된 재생본이 제공될 예정입니다.
Seer (Nasdaq: SEER), une entreprise pionnière dans le domaine des sciences de la vie axée sur la commercialisation de plateformes de protéomique, a annoncé sa participation à la 45e Conférence Annuelle sur la Santé de TD Cowen à Boston, MA.
L'équipe de direction de l'entreprise participera à un fireside chat prévu pour le mardi 4 mars à 11h50, heure de l'Est (8h50, heure du Pacifique). Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la session via la section Investisseur du site web de Seer à l'adresse investor.seer.bio. Un replay archivé sera disponible sur le site web de l'entreprise après la fin de la conférence.
Seer (Nasdaq: SEER), ein wegweisendes Unternehmen im Bereich der Lebenswissenschaften, das sich auf die Kommerzialisierung von Proteomik-Plattformen konzentriert, hat seine Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen in Boston, MA, angekündigt.
Das Management-Team des Unternehmens wird an einem Fireside Chat teilnehmen, der für Dienstag, den 4. März, um 11:50 Uhr Eastern Time (8:50 Uhr Pacific Time) angesetzt ist. Investoren und Interessierte können über den Investor-Bereich der Seer-Website unter investor.seer.bio auf einen Live-Webcast der Sitzung zugreifen. Eine archivierte Wiederholung wird nach Abschluss der Konferenz auf der Unternehmenswebsite zur Verfügung stehen.
- None.
- None.
REDWOOD CITY, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 45th Annual Healthcare Conference in Boston, MA.
Seer’s management is scheduled to participate in a fireside chat on Tuesday, March 4th at 11:50 a.m. Eastern Time / 8:50 a.m. Pacific Time. A live webcast of the session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.
About Seer
Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph™ Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.
Media Contact:
Patrick Schmidt
pr@seer.bio
Investor Contact:
Carrie Mendivil
investor@seer.bio
FAQ
When is Seer (SEER) presenting at the TD Cowen Healthcare Conference 2025?
How can investors watch Seer's presentation at the TD Cowen Conference?
What type of presentation will Seer (SEER) give at the TD Cowen Healthcare Conference?
Where is the TD Cowen Healthcare Conference featuring Seer taking place?
